Champions Oncology Income Statement

Financials in millions USD. Fiscal year is May - April.

Millions USD. Fiscal year is May - Apr.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Apr '26 Apr 30, 2026	Apr '25 Apr 30, 2025	Apr '24 Apr 30, 2024	Apr '23 Apr 30, 2023	Apr '22 Apr 30, 2022
Revenue	59.43	56.94	50.16	53.87	49.11
Revenue Growth	4.36%	13.54%	-6.90%	9.70%	19.66%
Cost of Revenue	30.9	28.39	29.4	29.53	23.63
Gross Profit	28.53	28.56	20.75	24.34	25.48
Selling, General & Admin	20.47	16.88	18.13	17.24	15.5
Research & Development	9.08	6.83	9.54	11.55	9.37
Other Operating Expenses	0.11	0.29	0.44	0.81	-
Total Operating Expenses	29.67	24	28.11	29.59	24.87
Operating Income	-1.14	4.55	-7.36	-5.26	0.61
Total Non-Operating Income (Expense)	0.21	0.07	0.05	-0.01	-0.02
Pretax Income	-0.93	4.63	-7.31	-5.27	0.58
Provision for Income Taxes	0.25	-0.08	-0.03	0.07	0.04
Net Income	-1.18	4.7	-7.28	-5.34	0.55
Net Income to Common	-1.18	4.7	-7.28	-5.34	0.55
Net Income Growth	-	-	-	-	51.38%
Shares Outstanding (Basic)	14	14	14	14	13
Shares Outstanding (Diluted)	14	14	14	14	14
Shares Change	-3.04%	5.31%	0.04%	-4.37%	-2.84%
EPS (Basic)	-0.08	0.34	-0.54	-0.39	0.04
EPS (Diluted)	-0.08	0.33	-0.54	-0.39	0.04
EPS Growth	-	-	-	-	100.00%
Free Cash Flow	-5.04	7	-6.97	1.1	4.11
Free Cash Flow Growth	-	-	-	-73.26%	-
Free Cash Flow Per Share	-0.36	0.49	-0.51	0.08	0.29
Gross Margin	48.00%	50.15%	41.38%	45.18%	51.88%
Operating Margin	-1.92%	8.00%	-14.67%	-9.76%	1.24%
Profit Margin	-1.98%	8.26%	-14.51%	-9.90%	1.12%
FCF Margin	-8.47%	12.29%	-13.90%	2.04%	8.38%
EBITDA	0.24	6.19	-5.49	-3.01	2.23
EBITDA Margin	0.40%	10.88%	-10.94%	-5.59%	4.55%
EBIT	-1.14	4.55	-7.36	-5.26	0.61
EBIT Margin	-1.92%	8.00%	-14.67%	-9.76%	1.24%
Effective Tax Rate	-26.48%	-1.62%	0.44%	-1.29%	6.00%

SEC Filings: 10-K · 10-Q